Giovanni Caforio
Board Member
Stryker Corp (SYK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Giovanni Caforio
Giovanni Caforio is recorded as Board Member at Stryker Corp (SYK). Earlier roles on record: CEO at Bristol Myers Squibb Co (BMY) until November 1, 2023. Bristol Myers Squibb Co reported in an 8-K filed April 26, 2023 that Giovanni Caforio retired as Chief Executive Officer, effective November 1, 2023. Giovanni Caforio has spoken on 15 earnings calls across 1 company, most recently for Bristol Myers Squibb Co on October 26, 2023.
“Dr. Caforio will continue to serve as Chairman of the Board until he retires as CEO on November 1, 2023, and after that will serve as Executive Chairman of the Board for a transition period to be determined by the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2023-11-01
-
Start not stated–2023-11-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Stryker Corp
Other people whose current roles at this company are on record from its filings.
- Glenn Boehnlein CEO
- Kevin A. Lobo CEO, Board Member
- Preston W. Wells CFO
- Preston Wells CFO
- Spencer Stiles COO
- Timothy J. Scannell COO
- Emily Baculik Chief Accounting Officer
- Andrew K. Silvernail Board Member
- Emmanuel P. Maceda Board Member
- Giovanni Caforio, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.